Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial

Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial

Introduction Diabetic kidney disease (DKD) is a prevalent and costly complication of diabetes with limited therapeutic options, being the leading cause of end-stage kidney disease in most developed regions. Recent big data studies showed that add-on Chinese medicine (CM) led to a reduced risk of end...

Full description

Bibliographic Details
Main Authors: Kathryn Choon Beng Tan, Lixing Lao, Kam Wa Chan, Alfred Siu Kei Kwong, Pun Nang Tsui, Simon Chi Yuen Cheung, Gary Chi Wang Chan, Wing Fai Choi, Wai Han Yiu, Michelle Man-Ying Wong, Zhang-Jin Zhang, Sydney Chi Wai Tang
Format: Article
Language:English
Published: BMJ Publishing Group 2021-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/1/e042686.full

Internet

https://bmjopen.bmj.com/content/11/1/e042686.full

Similar Items